Reducing Aβ deposition and memory loss protection can be achieved with NLRP3 suppression in APP/PS1 mice [14, 15], which implies NLRP3 inflammasome plays a critical role in AD pathology via regulating neuroinflammation [16]. This evidence concerns the gene APP and Alzheimer disease.